Novo Nordisk : NVO

All Novo Nordisk Articles

163 Articles

Omor Ibne Ehsan | Jan 22, 2025 at 11:15 AM EST

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Eli Lilly (NYSE: LLY | LLY Price Prediction) doesn’t really need much of an introduction. It has become a household…

Rich Duprey | Jan 21, 2025 at 3:15 PM EST

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Palantir Technologies (NASDAQ:PLTR | PLTR Price Prediction) has been described as the best pure-play stock in artificial intelligence. The market…

Rich Duprey | Jan 15, 2025 at 9:06 AM EST

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli Lilly…

Omor Ibne Ehsan | Dec 17, 2024 at 8:58 AM EST

Should You Buy the 3 Highest Yielding Dividend Stocks in the Dow Jones?

The Dow Jones is one of Wall Street’s most iconic benchmarks and it tracks 30 of America’s largest companies. It…

Will Ashworth | Nov 7, 2024 at 11:12 AM EST

These 3 Stocks Are Winning Thanks to Baby Boomers

According to a March 2023 study from the Bank of America Institute about consumer spending, seniors born in 1964 or…

Rich Duprey | Oct 3, 2024 at 7:53 PM EDT

Is John Paulson’s Best Investment Ever a Buy or Sell

The best investment billionaire John Paulson ever made was a bet against something. He famously predicted the collapse of the…

Trey Thoelcke | Sep 19, 2024 at 9:15 AM EDT

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are…

Rich Duprey | Sep 14, 2024 at 11:42 AM EDT

Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell

Jim Cramer is probably the closest thing we have to stock market superstar influencer. The host of CNBC’s “Mad Money”…

Ian Cooper | Sep 12, 2024 at 11:50 AM EDT

Five Top Obesity Stocks to Buy and Hold Long Term

Some of the best opportunities can still be found in obesity treatment stocks. Look at Viking Therapeutics (NASDAQ:VKTX | VKTX…

Joey Frenette | Sep 11, 2024 at 2:40 PM EDT

2 Weight Loss Drug Stocks Worth Stashing Away for Years

As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to…

Rich Duprey | Sep 8, 2024 at 12:32 PM EDT

2 Biotech Bets to Buy in September

Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or…

Rich Duprey | Sep 8, 2024 at 7:43 AM EDT

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

The release of OpenAI‘s ChatGPT chatbot in November 2022 unleashed a frenzy of investor interest in artificial intelligence that propelled…

Rich Duprey | Sep 3, 2024 at 4:37 PM EDT

Has Eli Lilly Destroyed Hims & Hers Upside?

Capitalizing on the popularity of weight-loss drugs like Wegovy and Zepbound, Hims & Hers Health (NYSE:HIMS) has exploited a loophole…

Chris MacDonald | Sep 1, 2024 at 9:12 AM EDT

3 GLP-1 Stocks to Buy Now For Big Long-Term Gains

The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive. Indeed, the growth various…

Rich Duprey | Aug 31, 2024 at 8:55 AM EDT

The Next 3 Stocks Ready to Cross the Trillion-Dollar Threshold

Remember when a stock becoming valued at $1 trillion was a big thing? The first company to do so was…

1 … 4 5 6 7 8 … 11

Novo Nordisk : NVO

All Novo Nordisk Articles

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Should You Buy the 3 Highest Yielding Dividend Stocks in the Dow Jones?

These 3 Stocks Are Winning Thanks to Baby Boomers

Is John Paulson’s Best Investment Ever a Buy or Sell

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell

Five Top Obesity Stocks to Buy and Hold Long Term

2 Weight Loss Drug Stocks Worth Stashing Away for Years

2 Biotech Bets to Buy in September

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

Has Eli Lilly Destroyed Hims & Hers Upside?

3 GLP-1 Stocks to Buy Now For Big Long-Term Gains

The Next 3 Stocks Ready to Cross the Trillion-Dollar Threshold

Is XRP (Ripple) Worth Holding Through 2026?

The 41-Day Dividend Trap That Quietly Erodes SPY Returns Every Quarter

Jim Cramer Just Named His Favorite Stock, and It’s the Comeback Nobody Saw Coming

You'll Spend Way Less in Retirement Than You Think | Bill Perkins Says the Data Is 'Overwhelming'

He Inherited $250,000 in His Wife's Roth, and Then Taxes Wiped Out Part of It

The 5-Year Roth Clock: Pull Your Earnings Too Early and the “Tax-Free” Account Hands You a Tax Bill

Is XRP (Ripple) Worth Holding Through 2026?

Novo Nordisk : NVO

All Novo Nordisk Articles

This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider

Billionaire Sold Palantir and Is Buying This Stock That Could Soar 237%, According to a Wall Street Expert

Down 23%, Is This Dividend Giant a Buy After GLP-1 Sales Miss?

Should You Buy the 3 Highest Yielding Dividend Stocks in the Dow Jones?

These 3 Stocks Are Winning Thanks to Baby Boomers

Is John Paulson’s Best Investment Ever a Buy or Sell

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell

Five Top Obesity Stocks to Buy and Hold Long Term

2 Weight Loss Drug Stocks Worth Stashing Away for Years

2 Biotech Bets to Buy in September

3 Crazy Stocks to Buy That Are Outperforming Nvidia in 2024

Has Eli Lilly Destroyed Hims & Hers Upside?

3 GLP-1 Stocks to Buy Now For Big Long-Term Gains

The Next 3 Stocks Ready to Cross the Trillion-Dollar Threshold

Is XRP (Ripple) Worth Holding Through 2026?

The 41-Day Dividend Trap That Quietly Erodes SPY Returns Every Quarter

Jim Cramer Just Named His Favorite Stock, and It’s the Comeback Nobody Saw Coming

Featured Reads

You'll Spend Way Less in Retirement Than You Think | Bill Perkins Says the Data Is 'Overwhelming'

He Inherited $250,000 in His Wife's Roth, and Then Taxes Wiped Out Part of It